Titican, Remark B.
HRN: 23-72-83 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2023
CEFUROXIME 750MG (VIAL)
09/24/2023
09/30/2023
IVT
750mg
Q8
Pneumonia
Waiting Final Action